Canbex Therapeutics

Antispastic small molecule drugs for multiple sclerosis

placeLondon, England, United Kingdom calendar_todayFounded 2005 groups1 employees language canbex.co.uk

Registered entities

Innovation

8 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 333 times.

YearFilings
20121
20133
20142
20157
20165
20174
20183

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital343%
Other / undisclosed457%
Coming soon